Table 4 Diagnostic performance of CAD-RADS for patient-based detection of significant CAD
Reviewer 1 | Reviewer 2 | Reviewer 3 | Reviewer 4 | |||||
|---|---|---|---|---|---|---|---|---|
% | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | |
Accuracy | 99.3 | 98.26 | 98.61 | 98.26 | ||||
Sensitivity | 100.00 | 97.22 to 100.00 | 100.00 | 97.22 to 100.00 | 100.00 | 97.22 to 100.00 | 100.00 | 97.22 to 100.00 |
Specificity | 98.72 | 95.45 to 99.84 | 96.79 | 92.68 to 98.95 | 97.44 | 93.57 to 99.30 | 97.44 | 93.57 to 99.30 |
AUC | 0.99 | 0.98 to 1.00 | 0.98 | 0.96 to 1.00 | 0.99 | 0.97 to 1.00 | 0.99 | 0.97 to 1.00 |
Disease prevalence | 45.64 | 39.78 to 51.60 | 45.64 | 39.78 to 51.60 | 45.64 | 39.78 to 51.60 | 45.64 | 39.78 to 51.60 |
Positive predictive value | 98.50 | 94.67 to 99.82 | 96.32 | 91.63 to 98.80 | 97.04 | 92.59 to 99.19 | 97.04 | 92.59 to 99.19 |
Negative predictive value | 100.00 | 97.63 to 100.00 | 100.00 | 97.59 to 100.00 | 100.00 | 97.60 to 100.00 | 100.00 | 97.60 to 100.00 |